The latest announcement is out from Mega Genomics Limited ( (HK:6667) ).
Mega Genomics Limited has announced a proposed change of auditor due to disagreements with Ernst & Young over audit time and costs for the 2024 financial statements. The company is seeking shareholder approval for this change at an extraordinary general meeting, as it aims to maintain audit quality and ensure timely access to its financial results. The company is currently in discussions with a potential new auditor and will provide updates in due course.
More about Mega Genomics Limited
Mega Genomics Limited is a company incorporated in the Cayman Islands, operating in the genomics industry. It is listed on the Hong Kong Stock Exchange and focuses on providing genomic services and products.
YTD Price Performance: -34.43%
Average Trading Volume: 106,059
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.61B
For a thorough assessment of 6667 stock, go to TipRanks’ Stock Analysis page.